1. Home
  2. CTKB vs AMBC Comparison

CTKB vs AMBC Comparison

Compare CTKB & AMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • AMBC
  • Stock Information
  • Founded
  • CTKB 1990
  • AMBC 1971
  • Country
  • CTKB United States
  • AMBC United States
  • Employees
  • CTKB N/A
  • AMBC N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AMBC Property-Casualty Insurers
  • Sector
  • CTKB Health Care
  • AMBC Finance
  • Exchange
  • CTKB Nasdaq
  • AMBC Nasdaq
  • Market Cap
  • CTKB 450.9M
  • AMBC 411.3M
  • IPO Year
  • CTKB 2021
  • AMBC 1991
  • Fundamental
  • Price
  • CTKB $3.61
  • AMBC $7.10
  • Analyst Decision
  • CTKB Hold
  • AMBC Strong Buy
  • Analyst Count
  • CTKB 4
  • AMBC 1
  • Target Price
  • CTKB $6.00
  • AMBC $15.00
  • AVG Volume (30 Days)
  • CTKB 1.6M
  • AMBC 952.1K
  • Earning Date
  • CTKB 08-05-2025
  • AMBC 08-04-2025
  • Dividend Yield
  • CTKB N/A
  • AMBC N/A
  • EPS Growth
  • CTKB N/A
  • AMBC N/A
  • EPS
  • CTKB N/A
  • AMBC N/A
  • Revenue
  • CTKB $197,050,000.00
  • AMBC $253,912,000.00
  • Revenue This Year
  • CTKB $0.91
  • AMBC N/A
  • Revenue Next Year
  • CTKB $7.75
  • AMBC $17.41
  • P/E Ratio
  • CTKB N/A
  • AMBC N/A
  • Revenue Growth
  • CTKB N/A
  • AMBC 125.08
  • 52 Week Low
  • CTKB $2.37
  • AMBC $5.99
  • 52 Week High
  • CTKB $7.63
  • AMBC $13.64
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 60.87
  • AMBC 47.08
  • Support Level
  • CTKB $3.38
  • AMBC $6.85
  • Resistance Level
  • CTKB $3.65
  • AMBC $7.22
  • Average True Range (ATR)
  • CTKB 0.21
  • AMBC 0.28
  • MACD
  • CTKB 0.04
  • AMBC 0.05
  • Stochastic Oscillator
  • CTKB 91.61
  • AMBC 79.61

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About AMBC Ambac Financial Group Inc.

Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.

Share on Social Networks: